Strategic Advocates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88K Sell
13
-2,103
-99% -$319K 0.01% 217
2025
Q4
$305K Sell
2,116
-931
-31% -$137K 0.08% 96
2025
Q3
$468K Buy
3,047
+106
+4% +$16.6K 0.12% 84
2025
Q2
$469K Buy
2,941
+393
+15% +$64.1K 0.14% 78
2025
Q1
$434K Buy
2,548
+271
+12% +$45.4K 0.15% 76
2024
Q4
$382K Sell
2,277
-435
-16% -$74.1K 0.13% 74
2024
Q3
$470K Buy
2,712
+281
+12% +$47.7K 0.17% 77
2024
Q2
$401K Sell
2,431
-1,616
-40% -$264K 0.16% 75
2024
Q1
$657K Buy
4,047
+2,135
+112% +$335K 0.25% 61
2023
Q4
$280K Buy
+1,912
New +$283K 0.12% 112

Other funds holding PG

Strategic Advocates's PG Position: Q1 2026 in Review

Strategic Advocates reduced its Procter & Gamble (PG) stake by 99% in Q1 2026, selling an estimated $319K and leaving 13 shares worth $1.88K. The position accounts for 0.01% of the portfolio, ranked #217.

Strategic Advocates first reported a position in PG in Q4 2023 and has held it in 10 quarters since. The position peaked at $657K in Q1 2024. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Strategic Advocates held 13 shares of Procter & Gamble worth $1.88K as of Q1 2026.
  • Strategic Advocates sold 2,103 Procter & Gamble shares in Q1 2026, an estimated $319K.
  • Procter & Gamble made up 0.01% of Strategic Advocates's portfolio in Q1 2026, its #217 holding.
  • Strategic Advocates first reported a position in Procter & Gamble in Q4 2023 and has held it in 10 quarters since.
  • Strategic Advocates's Procter & Gamble position peaked at $657K in Q1 2024.
  • 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.